GLUE - Monte Rosa Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.75
DETAILS
HIGH:
$37.00
LOW:
$22.00
MEDIAN:
$34.00
CONSENSUS:
$31.75
UPSIDE:
68.79%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 93.2% |
| EBIT Margin | -43.8% |
| EBITDA Margin | -37.1% |
| Operating Margin | -43.8% |
| Pretax Margin | -32.1% |
| Cont. Ops Margin | -31.2% |
| Net Margin | -31.2% |
| Bottom Line Margin | -31.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.12 |
| Quick Ratio | 6.12 |
| Solvency Ratio | -0.140 |
| Cash Ratio | 2.02 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-33.72
Peers avg: 15.1
|
| PEG Ratio | 0.64 |
| Forward PEG | 0.64 |
| Price/Book | 5.59 |
| Price/Sales | 10.53 |
| Price/FCF | -47.37 |
| Price/Op Cash Flow | -57.13 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0874 |
| Debt/Equity | 0.1682 |
| Debt/Capital | 0.1440 |
| Long-Term Debt/Capital | 0.1299 |
| Financial Leverage | 1.93 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.45 |
| Operating Cash Flow Ratio | -0.355 |
| Operating Cash Flow/Sales | -18.4% |
| Free Cash Flow/Operating Cash Flow | 120.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -10.18 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -5.18 |
| Operating Cash Flow Coverage | -0.58 |
| Capital Expenditure Coverage | -4.85 |
| Dividend + Capital Expenditure Coverage | -4.85 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.49 |
| EPS | -0.465 |
| Debt/Share | 0.4718 |
| Cash/Share | 4.54 |
| Book Value/Share | 2.81 |
| Tangible BV/Share | 2.81 |
| Equity/Share | 2.81 |
| Operating Cash Flow/Share | -0.274 |
| Capital Expenditure/Share | 0.057 |
| FCF/Share | -0.331 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.972 |
| Earnings Before Tax/EBIT | 0.733 |
| Price/Fair Value | 5.59 |
| Debt/Market Cap | 0.0301 |
| Effective Tax Rate | 2.8% |
| Enterprise Value Multiple | -26.43 |